Tenet Healthcare (THC) PT Raised to $231 at Wells Fargo

Mon, 13 Jul 2026 06:27:38 -0400

Wells Fargo analyst Stephen Baxter raised the price target on Tenet Healthcare (NYSE: THC) to $231.00 (from $213.00) while maintaining a Overweight rating.

Tenet Healthcare (THC) PT Raised to $240 at Barclays

Thu, 09 Jul 2026 05:01:13 -0400

Barclays analyst Andrew Mok raised the price target on Tenet Healthcare (NYSE: THC) to $240.00 (from $238.00) while maintaining a Overweight rating.

Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald

Thu, 02 Jul 2026 07:51:54 -0400

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $245.00 price target on Tenet Healthcare (NYSE: THC).

The analyst commented, "THC trends contributed to the segment takeaways of a rational & stable hiring market on inpatient acute & ASC/Outpatient nursing. Physician data were weaker though, as THC was the only provider to measurably increase / worsen its total physician openings. The increases were largely concentrated in FL & AZ and paired with increases / worsening on most bonus metrics."

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare

Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald on Consensus Cut

Wed, 01 Jul 2026 07:06:29 -0400

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $245.00 price target on Tenet Healthcare (NYSE: THC).

The analyst commented, "The 200bps step-down in consensus estimates on outpatient pricing to 3.6% in 2Q26 vs. 5.6% in 1Q26 contrasts with our more positive survey results on improving acuity, which is an area THC typically delivers on capturing volumes in. Similar to HCA, though, the volume read through is less compelling."

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $187.08 yesterday.

Tenet Healthcare (THC) PT Lowered to $233 at TD Cowen

Mon, 22 Jun 2026 08:27:09 -0400

TD Cowen analyst Ryan Langston lowered the price target on Tenet Healthcare (NYSE: THC) to $233.00 (from $242.00) while maintaining a Buy rating.

Tenet to Report Its Second Quarter 2026 Results on July 24

Mon, 22 Jun 2026 08:00:00 -0400

DALLAS--(BUSINESS WIRE)--

Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2026 results before the market opens on Friday, July 24, 2026, to be followed by a conference call at 10:30 a.m. CT (11:30 a.m. Eastern Time).

A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the

Tenet to Report Its Second Quarter 2026 Results on July 24

Mon, 22 Jun 2026 08:00:00 -0400

DALLAS--(BUSINESS WIRE)--

A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors.

About Tenet Healthcare

Tenet to Report Its Second Quarter 2026 Results on July 24

Mon, 22 Jun 2026 08:00:00 -0400

DALLAS--(BUSINESS WIRE)--

A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors.

About Tenet Healthcare

Tenet to Report Its Second Quarter 2026 Results on July 24

Mon, 22 Jun 2026 08:00:00 -0400

DALLAS--(BUSINESS WIRE)--

A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors.

About Tenet Healthcare

Jefferies recaps meetings with Healthcare Services companies